Journal Guide

J Mol Med publishes reports describing major advances in the understanding, prevention, diagnosis, and treatment of human disease through the application of molecular biology and gene technology, a research discipline that has become known as molecular medicine.  The journal publishes original papers and review articles of the highest quality pertinent to all aspects of human biology and pathophysiology. J Mol Med is the continuation of the Berliner Klinische Wochenschrift (1864), one of the oldest and most prestigious European journals in which great scientists such as Paul Ehrlich, Robert Koch and Otto Warburg published their seminal, epoch-making discoveries.

Machine Learning: Health is a multidisciplinary open access journal dedicated to the application of machine learning, artificial intelligence (AI) and data-driven computational methods across healthcare and the medical, biological, clinical, and health sciences. The journal also publishes research that presents methodological, theoretical, or conceptual advances in machine learning and AI with applications to medicine and health sciences.

Die medizinische genetik ist die größte Fachzeitschrift für klinische und allgemeine Humangenetik im deutschsprachigen Raum. Sie wird herausgegeben von der Deutschen Gesellschaft für Humangenetik (GfH). Ihr Fokus liegt auf der Fort- und Weiterbildung: namhafte Autoren vermitteln sowohl grundlagentheoretisches als auch anwendungsorientiertes Wissen in Form von Themenschwerpunkten und für die zertifizierte Fortbildung. Aktuelle Artikel zu Recht, Ethik und psychosozialen Aspekten der humangenetischen Diagnostik und Beratung verschaffen den Lesern einen breiten und fundierten Überblick über gegenwärtige gesundheitspolitische Diskussionen. Nicht zuletzt gibt die GfH durch die Veröffentlichung ihrer Stellungnahmen und Leitlinien in der Zeitschrift medizinische genetik konkrete Handlungsanweisungen und Orientierung für die kompetente Umsetzung humangenetischen Wissens im klinischen Alltag. Die Humangenetiker in Deutschland, Österreich und der Schweiz sind im Bereich Qualitätssicherung federführend in Eu

Meta Gene publishes meta-analysis, polymorphism and population study papers that are relevant to both human and non-human species. Examples include but are not limited to:(Relevant to human specimens):Meta-Analysis Papers - statistical reviews of the published literature of human genetic variation (typically linked to medical conditionals and/or congenital diseases)Genome Wide Association Studies (GWAS) - examination of large patient cohorts to identify common genetic factors that influence health and diseaseHuman Genetics Papers - original studies describing new data on genetic variation in smaller patient populationsGenetic Case Reports - short communications describing novel and in formative genetic mutations or chromosomal aberrations (e.g., probands) in very small demographic groups (e.g., family or unique ethnic group).(Relevant to non-human specimens):Small Genome Papers - Analysis of genetic variation in organelle genomes (e.g., mitochondrial DNA)Microbiota Papers - Analysis of microbiological variation through analysis of DNA sequencing in different biological environmentsEcological Diversity Papers - Geographical distribution of genetic diversity of zoological or botanical species.

Molecular Cytogenetics encompasses all aspects of chromosome biology and the application of molecular cytogenetic techniques in all areas of biomedicine.

Molecular Genetics & Genomic Medicine is a peer-reviewed journal for rapid dissemination of quality research related to the dynamically developing areas of human, molecular and medical genetics. The journal publishes original research articles covering findings in phenotypic, molecular, biological, and genomic aspects of genomic variation, inherited disorders and birth defects. The broad publishing spectrum of Molecular Genetics & Genomic Medicine includes rare and common disorders from diagnosis to treatment. Examples of appropriate articles include reports of novel disease genes, functional studies of genetic variants, in-depth genotype-phenotype studies, genomic analysis of inherited disorders, molecular diagnostic methods, medical bioinformatics, ethical, legal, and social implications (ELSI), and approaches to clinical diagnosis. Molecular Genetics & Genomic Medicine provides a scientific home for next generation sequencing studies of rare and common disorders, which will make research in this fascinating area easily and rapidly accessible to the scientific community. This will serve as the basis for translating next generation sequencing studies into individualized diagnostics and therapeutics, for day-to-day medical care.

Molecular Genetics & Genomic Medicine publishes original research articles, reviews, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented.

Molecular Genetics & Genomic Medicine is a Wiley Open Access journal, one of a series of peer reviewed titles publishing quality research with speed and efficiency. Authors of accepted papers pay an Article Publication Charge and their papers are published under a Creative Commons license. With Creative Commons licenses, the author retains copyright and the public is allowed to reuse the content. The author grants Wiley a license to publish the article and identify as the original publisher. To find out which Created Commons Licenses are available for the journal, click here. For further information, visit the Wiley Open Access website.

Molecular Medicine is the international, peer-reviewed, biomedical journal published by the Feinstein Institute for Medical Research (New York). Molecular Medicine strives to understand normal body functioning and disease pathogenesis at the molecular level, which may allow researchers and physician-scientists to use that knowledge in the design of specific molecular tools for disease diagnosis, treatment, prognosis, and prevention. Manuscripts submitted to the journal should maintain this focus and describe the implications for human disease, at a level approachable by the broad readership of Molecular Medicine. The 2011 Journal Citation Report (JCR), showing impact factors calculated from citations of articles published in 2010 and 2009, lists Molecular Medicine with an impact factor of 3.757. JCR category rankings are as follows: Medicine, Research & Experimental 24/111, Cell Biology 72/180, Biochemistry & Molecular Biology 91/289. Molecular Medicine publishes work in the format of original research articles, review articles, editorials, commentaries and letters to the editor covering emerging concepts in the interdisciplinary field of molecular medicine.Molecular Medicine places high priority on rapid publication. All content is published free online, ahead of print, within an average of 8 days after acceptance on our Web site www.molmed.org. Following acceptance, papers are posted rapidly to PubMed, with an e-publication ahead of print citation. Molecular Medicine is an open access journal and does not embargo content.

Molecular Syndromology publishes high-quality research articles, short reports, and reviews on common and rare genetic syndromes, aiming to increase clinical understanding through molecular insights. Topics of particular interest are the molecular basis of genetic syndromes, genotype-phenotype correlation, natural history, strategies in disease management and novel therapeutic approaches based on molecular findings. Research on model systems is also welcome, especially when it is obviously relevant to human genetics. With high-quality reviews on current topics, the journal aims to facilitate translation of research findings to a clinical setting while also stimulating further research on clinically relevant questions. The journal targets not only medical geneticists and basic biomedical researchers, but also clinicians dealing with genetic syndromes. With 4 associate editors from 3 continents and a broad international editorial board, the journal welcomes submissions covering the lates

Mutagenesis is an international multi-disciplinary journal designed to bring together research aimed at the identification, characterization and elucidation of the mechanisms of action of physical, chemical and biological agents capable of producing genetic change in living organisms and the study of the consequences of such changes.

To an extent, all life scientists are geneticists because genetic technology and the accumulation of genomic information have enriched all of biology. You may or may not call yourself a geneticist, but if you work on or with genes you need to know about the latest developments. Nature Reviews Genetics covers the full scientific breadth of modern genetics, capturing its excitement, diversity and implications.Subjects covered * Genomics: genome sequencing, genome projects, bioinformatics, cancer genomics, metagenomics, pharmacogenomics, resources * Functional genomics: transcriptomics, functional genomics screens, bioinformatics * Evolutionary genetics: evo-devo, genome evolution, comparative genomics, population genetics, phylogenetics * Technology: new techniques, experimental strategies, therapy, applied genetics and genomics, computational biology * Gene expression: gene regulatory elements, transcriptional and post-transcriptional regulation, regulatory RNAs, broad perspectives on gene regulation, gene expression profiling, gene regulatory networks * Multifactorial genetics: complex traits, mapping strategies, technology, genetic variation * Disease: disease gene identification, relationship between genotype and phenotype, molecular pathology of genetic disease, complex disease, disease susceptibility/resistance * Chromosome biology: DNA elements, telomeres, centromeres, mobile elements, chromosome stability, DNA damage, meiosis and mitosis, nuclear organization, artificial chromosomes * Epigenetics: DNA methylation, histone modification, chromatin structure, imprinting, chromatin remodeling, epigenomics * Developmental biology: patterning, differentiation, stem cells, reproductive technology * Systems and networks: systems biology, biological networks, synthetic biology, modelling * Ethical, legal and social implications of genetics and genomics.

neurology, neurogenetics, genetic disease risk, pharmacogenomics

This international, multidisciplinary journal covers all aspects of neuromuscular disorders in childhood and adult life (including the muscular dystrophies, spinal muscular atrophies, hereditary neuropathies, congenital myopathies, myasthenias, myotonic syndromes, metabolic myopathies and inflammatory myopathies).The Editors welcome original articles from all areas of the field:• Clinical aspects, such as new clinical entities, case studies of interest, treatment, management and rehabilitation (including biomechanics, orthotic design and surgery).• Basic scientific studies of relevance to the clinical syndromes, including advances in the fields of molecular biology and genetics.• Studies of animal models relevant to the human diseases.The journal is aimed at a wide range of clinicians, pathologists, associated paramedical professionals and clinical and basic scientists with an interest in the study of neuromuscular disorders.In addition to original research papers, the journal also publishes reviews and mini-reviews, preliminary short communications and book reviews, and has editorial, correspondence and news sections. Reports on congresses and workshops, taking the form of a digested or very comprehensive commentary, pointing out some of the particular highlights in relation to the contributors and giving some detail of the area covered, important contributions and a list of participants, are also welcome.The journal is published monthly and aims at rapid publication of high quality papers of scientific merit as well as general interest to a wide readership. There is also a fast track for rapid publication of new material of outstanding scientific merit and importance.Neuromuscular Disorders is the official journal of the World Muscle Society an international, multidisciplinary, scientific society, dedicated to the advancement and dissemination of knowledge in the field of neuromuscular disorders.

Ophthalmic Genetics accepts original papers, review articles and short communications on the clinical and molecular genetic aspects of ocular diseases. The journal invites several types of contributions divided into sections:

The official journal of Orphanet, the European portal for rare diseases and orphan drugs Orphanet Journal of Rare Diseases is an open access, online journal that encompasses all aspects of rare diseases and orphan drugs. The journal publishes high quality reviews solicited from experts in the field and also considers research on new syndromes and results of clinical trials of exceptional interest.

Genetics and genomics research has grown at a bewildering pace in the past 15 years. The techniques of these fields are being applied to a wealth of biological questions and experimental systems. PLoS Genetics reflects the full breadth and interdisciplinary nature of this research by publishing outstanding original contributions in all areas of biology.PLoS Genetics publishes human studies, as well as research on model organisms—from mice and flies, to plants and bacteria. Our emphasis is on studies of broad interest that provide significant mechanistic insight into a biological process or processes. Topics include (but are not limited to) gene discovery and function, population genetics, genome projects, comparative and functional genomics, medical genetics, disease biology, evolution, gene expression, complex traits, chromosome biology, and epigenetics.Please refer to our Author Guidelines and Frequently Asked Questions when you are preparing manuscripts for submission. If you are unsure whether your work is suitable for PLoS Genetics, you can send a Presubmission Inquiry.

Pharmacogenetics and Genomics is a unique and innovative journal that covers genetic variation in response to drugs and other chemicals in humans and animals. Its impressive impact factor rating of 4.409 (Pharmacology and Pharmacy, Genetics and Heredity, and Biotechnology & Applied Microbiology, 2008 SCI169; Report) is testament to its quality and standing in this field.Pharmacogenetics and Genomics unites contributions of importance to clinical pharmacologists, biochemists, geneticists, epidemiologists and molecular biologists. The journal publishes studies that identify and characterize polymorphic genes encoding drug metabolizing enzymes, drug receptors and drug transporters. Coverage also includes papers on the effects of gene expression on the disposition and metabolism of foreign chemicals.Full text online at www.pharmacogeneticsandgenomics.com.

Prenatal Diagnosis communicates the results of clinical and basic research in prenatal and preimplantation diagnosis in humans, and animal and in vitro models, encompassing:

Psychiatric Genetics addresses new areas of research which have been opened up following the success of new technology in cloning many genes related to brain structure and function. The journal publishes groundbreaking papers that bring together clinical observations, psychological abnormalities and genetic marker data. Areas such as twin studies, adoption studies, genetic/biological markers and family/pedigree studies also fall within the scope. Website: www.psychgenetics.com.

Public Health Genomics is the leading international journal focusing on the timely translation of genome-based knowledge and technologies into public health, health policies, and health care as a whole. This peer-reviewed journal is a bimonthly forum featuring original papers, reviews, short communications, and policy statements. It is supplemented by topic-specific issues providing a comprehensive, holistic, and “all-inclusive” picture of the chosen subject. Multidisciplinary in scope, it combines theoretical and empirical work from a range of disciplines, notably public health, molecular and medical sciences, the humanities, and social sciences. In so doing, it also takes into account rapid scientific advances from fields such as systems biology, microbiomics, epigenomics, or information and communication technologies as well as the high potential of “big data” for public health.
What was until very recently no more than a vision for a new era of public health, in which advances in the “-omic” sciences would be integrated into strategies aiming at benefiting population health, has now become a response to the very pressing need for the development of effective personalized health care which is complementary to health protection and health promotion. The aim of Public Health Genomics is to facilitate a broad dialogue between academia, the private sector, and government bodies.